AU2022900640A0 - Compositions and methods for treating neurological disorders - Google Patents

Compositions and methods for treating neurological disorders

Info

Publication number
AU2022900640A0
AU2022900640A0 AU2022900640A AU2022900640A AU2022900640A0 AU 2022900640 A0 AU2022900640 A0 AU 2022900640A0 AU 2022900640 A AU2022900640 A AU 2022900640A AU 2022900640 A AU2022900640 A AU 2022900640A AU 2022900640 A0 AU2022900640 A0 AU 2022900640A0
Authority
AU
Australia
Prior art keywords
compositions
methods
neurological disorders
treating neurological
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022900640A
Inventor
unknown unknown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurotech International Ltd
Original Assignee
Neurotech International Ltd
Filing date
Publication date
Application filed by Neurotech International Ltd filed Critical Neurotech International Ltd
Publication of AU2022900640A0 publication Critical patent/AU2022900640A0/en
Priority to IL311852A priority Critical patent/IL311852A/en
Priority to KR1020247015056A priority patent/KR20240090332A/en
Priority to EP22879679.3A priority patent/EP4415738A1/en
Priority to CA3231509A priority patent/CA3231509A1/en
Priority to PCT/AU2022/051220 priority patent/WO2023060301A1/en
Priority to JP2024518588A priority patent/JP2024536075A/en
Priority to AU2022361940A priority patent/AU2022361940A1/en
Pending legal-status Critical Current

Links

AU2022900640A 2021-10-11 2022-03-16 Compositions and methods for treating neurological disorders Pending AU2022900640A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL311852A IL311852A (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders
KR1020247015056A KR20240090332A (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders
EP22879679.3A EP4415738A1 (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders
CA3231509A CA3231509A1 (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders
PCT/AU2022/051220 WO2023060301A1 (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders
JP2024518588A JP2024536075A (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders
AU2022361940A AU2022361940A1 (en) 2021-10-11 2022-10-11 Compositions and methods for treating neurological disorders

Publications (1)

Publication Number Publication Date
AU2022900640A0 true AU2022900640A0 (en) 2022-03-31

Family

ID=

Similar Documents

Publication Publication Date Title
EP3917620A4 (en) Compositions and methods for treating neurocognitive disorders
EP3917539A4 (en) Compositions and methods for treating neurocognitive disorders
EP4210755A4 (en) Compositions and methods for the treatment of neurological disorders
EP3979985A4 (en) Compositions and methods for treating central nervous system disorders
EP4188368A4 (en) Compositions and methods for treating diseases and disorders
EP4096439A4 (en) Compositions and methods for treating aging-related disorders
IL311854A (en) Compositions and methods for treating neurological disorders with combination products
EP3917623A4 (en) Compositions and methods for treating neurocognitive disorders
EP3927342A4 (en) Compounds and methods of deuterated xanomeline for treating neurological disorders
EP4208159A4 (en) Compositions and methods for improving neurological diseases and disorders
EP4165025A4 (en) Compositions and methods for the treatment and prevention of neurological disorders
IL311852A (en) Compositions and methods for treating neurological disorders
AU2022901710A0 (en) Compositions and methods for treating neurological disorders
AU2022900640A0 (en) Compositions and methods for treating neurological disorders
EP3735129A4 (en) Compositions and methods for treating neurological and other disorders
AU2021903256A0 (en) Compositions and methods for treating neurological disorders
EP4136103A4 (en) Compositions and methods for treating neuropsychiatric disorders
EP4103177A4 (en) Compositions and methods for treating and/or preventing ocular disorders
EP4219450A4 (en) 6-methoxy-2-phenethyl isoindoline-1-one derivative and composition for treating neurological disorders, comprising same
AU2022903123A0 (en) Compositions and methods for treating disorders
EP4135661A4 (en) Compositions and methods for treatment of neurological disorders
EP4175978A4 (en) Compositions and methods for treating crp-mediated diseases
EP4076429A4 (en) Compositions and methods for treating neuromuscular disorders
AU2022901714A0 (en) Compositions and methods for treating neurological disorders with combination products
AU2022900642A0 (en) Compositions and methods for treating neurological disorders with combination products